Clinical trial / 1994
Beta carotene supplementation increased lung cancer and overall mortality in male smokers.
A trial of 29,133 male smokers aged 50 to 69 years examined daily supplementation with alpha-tocopherol (50 mg), beta carotene (20 mg), both, or placebo for 5 to 8 years. Alpha-tocopherol did not significantly change lung cancer incidence (-2%; 95% CI, -14% to 12%). Beta carotene supplementation increased lung cancer incidence by 18% (95% CI, 3% to 36%) and total mortality by 8% (95% CI, 1% to 16%).
- Study type
- Randomized controlled trial
- Who was studied
- 29,133 male smokers aged 50 to 69 years, Finland
- What was measured
- Incidence of lung cancer, other cancers, and total mortality
THE PAPER
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.
Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med, 1994.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.